Yang Wen-Dan, Dong Wei-Guo
College of Acupuncture and Moxibustion, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
College of Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Zhen Ci Yan Jiu. 2020 May 25;45(5):426-31. doi: 10.13702/j.1000-0607.180885.
Alzheimer's disease (AD), a neurodegenerative disorder characterized by amyloid deposits and neurofibrillary degeneration, is the most common type of dementia and has no incurable therapies at the moment. Electroacupuncture (EA) therapy has been widely used in clinical treatment of AD, and has attained approving effects. This article reviews the development of researches on the mechanisms of EA underlying improving AD by diminishing β amyloid protein (Aβ) neurotoxicity, from 1) up-regulating hippocampal cellular autophagy, 2) improving cerebral energy metabolism by activating oxidation stress-related factors peroxisome proliferator-activated receptor γ coactivator 1 alpha and sirtuin 1 in the hippocampus and frontal cerebral cortex, 3) relieving inflammatory reaction by lowering expression of tumor necrosis factor-alpha and high-mobility group box 1 and increasing expression of Interleukin 10, and 4) promoting degradation of Aβ by down-regulating expression of insulin degeneration enzyme, lipoprotein, transthyretin, apolipoprotein and α2 mcroglobulin. Meanwhile, a comprehensive clinical therapy of AD is proposed.
阿尔茨海默病(AD)是一种以淀粉样蛋白沉积和神经原纤维变性为特征的神经退行性疾病,是最常见的痴呆类型,目前尚无治愈方法。电针(EA)疗法已广泛应用于AD的临床治疗,并取得了满意的效果。本文综述了电针通过减轻β淀粉样蛋白(Aβ)神经毒性改善AD的机制的研究进展,包括:1)上调海马细胞自噬;2)通过激活海马和额叶皮质中氧化应激相关因子过氧化物酶体增殖物激活受体γ共激活因子1α和沉默调节蛋白1来改善脑能量代谢;3)通过降低肿瘤坏死因子-α和高迁移率族蛋白B1的表达以及增加白细胞介素10的表达来减轻炎症反应;4)通过下调胰岛素降解酶、脂蛋白、转甲状腺素蛋白、载脂蛋白和α2微球蛋白的表达来促进Aβ的降解。同时,提出了AD的综合临床治疗方案。